Encouraging Results with Obinutuzumab for Lupus Nephritis
February 13, 2022
The LRA is pleased to share a recently published paper reporting that the drug, obinutuzumab, showed positive...
News
LRA-Funded Research Aims at Preventing Heart Disease in Kids With Lupus
February 14, 2022
Being a kid isn't always easy, but growing up with lupus makes it a much harder challenge....
LRA-Funded Research Found a Connection Between the Epstein-Barr Virus Infection and MS as an Autoimmune Disease
February 4, 2022
A potential new cause of the autoimmune disease multiple sclerosis (MS) was discovered by researchers partly funded...
Baricitinib Development as a Lupus Treatment Discontinued
January 28, 2022
The Lupus Research Alliance is disappointed that the Phase 3 development program of OLUMIANT® (baricitinib) as a...
LRA-Funded Research Uncovers a Novel Pathway for Lupus Nephritis
January 28, 2022
The investigators from The Accelerated Medicines Partnership® Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP® RA/SLE) Program, in...
Lupus Research Alliance Launches Two Major Initiatives to Increase Participation of Underrepresented Minorities in Lupus Clinical Trials and Research
NEW YORK, NY. January 27 — The Lupus Research Alliance (LRA) and clinical affiliate Lupus Therapeutics (LT) announced two major initiatives improving representation...
Shingles Vaccine Recommended for Immunocompromised People
January, 2022
As of January, 2022, the U.S. Centers for Disease Control and Prevention (CDC) recommends the use of the...
Lupus Research Alliance Announces 11 Exceptional Recipients of the 2021 Lupus Innovation Award
NEW YORK, NY, December 14, 2021. The Lupus Research Alliance proudly announced today recipients from the U.S. and around...
FDA Authorizes Evusheld Emergency Use to Prevent COVID-19 in Immunocompromised Patients
December 9, 2021
People with lupus can be immunocompromised because of the disease itself or medications that suppress the immune...
Aurinia Announces Positive Long-Term Results on Lupykinis™ for Lupus Nephritis
December 9, 2021
The LRA is pleased to share positive topline three-year efficacy and safety results reported today by Aurinia...
LRA Partnering with NIH, FNIH and Others on Groundbreaking Initiative
December 9, 2021
The Lupus Research Alliance (LRA) is proud and excited to partner again with the National Institutes of...
Lupus Research Alliance Breaking Through Gala Sets New Record, Raising $7.5 Million for Lupus Research
New York, NY. November 23, 2021 – Last night’s Lupus Research Alliance (LRA) Breaking Through Gala was the most successful...